Literature DB >> 5001959

Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci.

R C Moellering, A N Weinberg.   

Abstract

The mechanism by which agents that inhibit bacterial cell wall synthesis produce a synergistic effect against enterococci when combined with aminoglycoside antibiotics has not been elucidated. Using (14)C-labeled streptomycin, it could be shown that uptake of this aminoglycoside antibiotic was markedly enhanced in enterococci growing in the presence of penicillin or other agents which inhibit the synthesis of bacterial cell walls. There was no enhancement of streptomycin uptake when the cells were incubated with antibiotics which primarily affect the bacterial cell membrane or inhibit protein synthesis. Increased streptomycin uptake was produced by penicillin only in actively growing bacteria. These observations are consistent with the hypothesis that enterococci exhibit a natural barrier to the entry of streptomycin which can be overcome by agents which inhibit cell wall synthesis, thus producing a synergistic effect.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5001959      PMCID: PMC292207          DOI: 10.1172/JCI106758

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

1.  A simple scintillation counting technique for assaying C1402 in a Warburg flask.

Authors:  D R BUHLER
Journal:  Anal Biochem       Date:  1962-11       Impact factor: 3.365

2.  Synergism between streptomycin and penicillin: a proposed mechanism.

Authors:  P H PLOTZ; B D DAVIS
Journal:  Science       Date:  1962-03-23       Impact factor: 47.728

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Kinetics of the synergism of penicillin-streptomycin and penicillin-kanamycin for enterococci and its relationship to L-phase variants.

Authors:  W L Hewitt; S J Seligman; R A Deigh
Journal:  J Lab Clin Med       Date:  1966-05

Review 5.  Present status of therapy with combinations of antibiotics.

Authors:  H F Dowling
Journal:  Am J Med       Date:  1965-11       Impact factor: 4.965

6.  Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center.

Authors:  G L Mandell; D Kaye; M E Levison; E W Hook
Journal:  Arch Intern Med       Date:  1970-02

7.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

8.  Mechanism of resistance to antibiotic synergism in enterococci.

Authors:  R A Zimmermann; R C Moellering; A N Weinberg
Journal:  J Bacteriol       Date:  1971-03       Impact factor: 3.490

9.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

10.  Inhibition by antibiotics of the growth of bacterial and yeast protoplasts.

Authors:  G D SHOCKMAN; J O LAMPEN
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

  10 in total
  70 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  An improved microbiological procedure for detection of streptomycin residues in milk and animal tissues.

Authors:  H Søgaard
Journal:  Acta Vet Scand       Date:  1979       Impact factor: 1.695

3.  Synergism and antagonism among antimicrobial drugs. A personal perspective.

Authors:  E Jawetz
Journal:  West J Med       Date:  1975-08

Review 4.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

5.  Aminoglycoside therapy: current and prospective uses.

Authors:  J E Leggett
Journal:  Tex Heart Inst J       Date:  1990

6.  The enterococci: an enigma and a continuing therapeutic challenge.

Authors:  R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 7.  Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.

Authors:  Sebastiano Leone; Silvana Noviello; Silvano Esposito
Journal:  Infection       Date:  2015-09-01       Impact factor: 3.553

8.  The structures of penicillin-binding protein 4 (PBP4) and PBP5 from Enterococci provide structural insights into β-lactam resistance.

Authors:  Thomas M Moon; Éverton D D'Andréa; Christopher W Lee; Alexei Soares; Jean Jakoncic; Charlene Desbonnet; Monica Garcia-Solache; Lou B Rice; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

Review 9.  The Enterococcus: a Model of Adaptability to Its Environment.

Authors:  Mónica García-Solache; Louis B Rice
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

10.  Effect of disruption of a gene encoding an autolysin of Enterococcus faecalis OG1RF.

Authors:  X Qin; K V Singh; Y Xu; G M Weinstock; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.